Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema

Background: The impact of recurrent angioedema can be severely debilitating and remains difficult to quantify. Several standardized patient-reported outcome measures (PROMs), including the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test...

Full description

Saved in:
Bibliographic Details
Main Authors: Hugo W.F. Mak, MBBS, Jane C.Y. Wong, MBBS, Sophia W.M. So, MBBS, Dorothy L.Y. Lam, MSc, Karsten Weller, MD, Marcus Maurer, MD, Philip H. Li, MBBS, MD
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829324000912
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846169351223246848
author Hugo W.F. Mak, MBBS
Jane C.Y. Wong, MBBS
Sophia W.M. So, MBBS
Dorothy L.Y. Lam, MSc
Karsten Weller, MD
Marcus Maurer, MD
Philip H. Li, MBBS, MD
author_facet Hugo W.F. Mak, MBBS
Jane C.Y. Wong, MBBS
Sophia W.M. So, MBBS
Dorothy L.Y. Lam, MSc
Karsten Weller, MD
Marcus Maurer, MD
Philip H. Li, MBBS, MD
author_sort Hugo W.F. Mak, MBBS
collection DOAJ
description Background: The impact of recurrent angioedema can be severely debilitating and remains difficult to quantify. Several standardized patient-reported outcome measures (PROMs), including the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT), have been developed and translated into different languages. However, these PROMs have yet to be validated in Chinese individuals, and their correlations in the Chinese population remain unknown. Objective: Our aim was to validate the Chinese versions of the AAS, AE-QoL questionnaire, and AECT and assess their intercorrelations. Methods: A prospective cohort of 118 Chinese patients with recurrent angioedema at the Angioedema and Urticaria Centre of Reference and Excellence in Hong Kong completed the traditional Chinese versions of the AAS, AE-QoL questionnaire, and AECT. We analyzed the reliability and validity of these PROMs and their correlations with each other as well as with generic PROMs. Results: The Chinese AAS, AE-QoL questionnaire, and AECT demonstrated excellent internal consistency (Cronbach α = 0.920, 0.976, and 0.832, respectively; McDonald ω = 0.972, 0.977, and 0.901, respectively). Confirmatory factor analysis for the AE-QoL questionnaire showed an acceptable fit with the 4-dimensional model (comparative fit index = 0.869; Tucker-Lewis index = 0.842). The AECT showed significant correlations with both the AAS and AE-QoL questionnaire (ρ = –0.750 and –0.456 respectively [both P < .05]). The AE-QoL questionnaire was moderately correlated with certain domains of generic PROMs such as the Work Productivity and Activity Impairment Questionnaire: General Health, version 2.0, and the Short Form 12-Item Health Survey, version 2 (all ρ < 0.60). Conclusion: The Chinese AE-QoL questionnaire, AAS, and AECT are valid and reliable tools for use with Chinese patients. More validated tools should be made available to improve patient care and research for all patients with angioedema globally.
format Article
id doaj-art-8e6c2b725e5c45b5a287da7b80f5e924
institution Kabale University
issn 2772-8293
language English
publishDate 2024-11-01
publisher Elsevier
record_format Article
series Journal of Allergy and Clinical Immunology: Global
spelling doaj-art-8e6c2b725e5c45b5a287da7b80f5e9242024-11-13T04:30:42ZengElsevierJournal of Allergy and Clinical Immunology: Global2772-82932024-11-0134100295Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedemaHugo W.F. Mak, MBBS0Jane C.Y. Wong, MBBS1Sophia W.M. So, MBBS2Dorothy L.Y. Lam, MSc3Karsten Weller, MD4Marcus Maurer, MD5Philip H. Li, MBBS, MD6Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, ChinaDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, ChinaDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, ChinaDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, ChinaInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Immunology and Allergology, Berlin, GermanyInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Immunology and Allergology, Berlin, GermanyDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China; Corresponding author: Philip H. Li, MBBS, MD, Division of Rheumatology and Clinical Immunology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong.Background: The impact of recurrent angioedema can be severely debilitating and remains difficult to quantify. Several standardized patient-reported outcome measures (PROMs), including the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT), have been developed and translated into different languages. However, these PROMs have yet to be validated in Chinese individuals, and their correlations in the Chinese population remain unknown. Objective: Our aim was to validate the Chinese versions of the AAS, AE-QoL questionnaire, and AECT and assess their intercorrelations. Methods: A prospective cohort of 118 Chinese patients with recurrent angioedema at the Angioedema and Urticaria Centre of Reference and Excellence in Hong Kong completed the traditional Chinese versions of the AAS, AE-QoL questionnaire, and AECT. We analyzed the reliability and validity of these PROMs and their correlations with each other as well as with generic PROMs. Results: The Chinese AAS, AE-QoL questionnaire, and AECT demonstrated excellent internal consistency (Cronbach α = 0.920, 0.976, and 0.832, respectively; McDonald ω = 0.972, 0.977, and 0.901, respectively). Confirmatory factor analysis for the AE-QoL questionnaire showed an acceptable fit with the 4-dimensional model (comparative fit index = 0.869; Tucker-Lewis index = 0.842). The AECT showed significant correlations with both the AAS and AE-QoL questionnaire (ρ = –0.750 and –0.456 respectively [both P < .05]). The AE-QoL questionnaire was moderately correlated with certain domains of generic PROMs such as the Work Productivity and Activity Impairment Questionnaire: General Health, version 2.0, and the Short Form 12-Item Health Survey, version 2 (all ρ < 0.60). Conclusion: The Chinese AE-QoL questionnaire, AAS, and AECT are valid and reliable tools for use with Chinese patients. More validated tools should be made available to improve patient care and research for all patients with angioedema globally.http://www.sciencedirect.com/science/article/pii/S2772829324000912AngioedemaChinesechronic urticariahereditary angioedemapatient-reported outcome measuresvalidation
spellingShingle Hugo W.F. Mak, MBBS
Jane C.Y. Wong, MBBS
Sophia W.M. So, MBBS
Dorothy L.Y. Lam, MSc
Karsten Weller, MD
Marcus Maurer, MD
Philip H. Li, MBBS, MD
Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema
Journal of Allergy and Clinical Immunology: Global
Angioedema
Chinese
chronic urticaria
hereditary angioedema
patient-reported outcome measures
validation
title Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema
title_full Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema
title_fullStr Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema
title_full_unstemmed Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema
title_short Validation and correlations of the Angioedema Activity Score (AAS), Angioedema Quality of Life (AE-QoL) questionnaire, and Angioedema Control Test (AECT) in Chinese patients with angioedema
title_sort validation and correlations of the angioedema activity score aas angioedema quality of life ae qol questionnaire and angioedema control test aect in chinese patients with angioedema
topic Angioedema
Chinese
chronic urticaria
hereditary angioedema
patient-reported outcome measures
validation
url http://www.sciencedirect.com/science/article/pii/S2772829324000912
work_keys_str_mv AT hugowfmakmbbs validationandcorrelationsoftheangioedemaactivityscoreaasangioedemaqualityoflifeaeqolquestionnaireandangioedemacontroltestaectinchinesepatientswithangioedema
AT janecywongmbbs validationandcorrelationsoftheangioedemaactivityscoreaasangioedemaqualityoflifeaeqolquestionnaireandangioedemacontroltestaectinchinesepatientswithangioedema
AT sophiawmsombbs validationandcorrelationsoftheangioedemaactivityscoreaasangioedemaqualityoflifeaeqolquestionnaireandangioedemacontroltestaectinchinesepatientswithangioedema
AT dorothylylammsc validationandcorrelationsoftheangioedemaactivityscoreaasangioedemaqualityoflifeaeqolquestionnaireandangioedemacontroltestaectinchinesepatientswithangioedema
AT karstenwellermd validationandcorrelationsoftheangioedemaactivityscoreaasangioedemaqualityoflifeaeqolquestionnaireandangioedemacontroltestaectinchinesepatientswithangioedema
AT marcusmaurermd validationandcorrelationsoftheangioedemaactivityscoreaasangioedemaqualityoflifeaeqolquestionnaireandangioedemacontroltestaectinchinesepatientswithangioedema
AT philiphlimbbsmd validationandcorrelationsoftheangioedemaactivityscoreaasangioedemaqualityoflifeaeqolquestionnaireandangioedemacontroltestaectinchinesepatientswithangioedema